Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Apr 6;5(6):787.
doi: 10.4022/jafib.787. eCollection 2013 Apr-May.

Role of Atrio-Ventricular Junction Ablation in Symptomatic Atrial Fibrillation for Optimization of Cardiac Resynchronization Therapy

Paul J Garabelli  1 , Stavros Stavrakis  1
Affiliations
Review

Role of Atrio-Ventricular Junction Ablation in Symptomatic Atrial Fibrillation for Optimization of Cardiac Resynchronization Therapy

Paul J Garabelli et al. J Atr Fibrillation. .

Abstract

Cardiac resynchronization (CRT) therapy is indicated in patients with at least mildly symptomatic heart failure, left ventricular ejection fraction ≤35% and wide QRS, and has been associated with decreased morbidity and mortality. Unfortunately, approximately 30% of the patients appropriately selected for therapy do not respond to CRT. Among the reasons for non-response, atrial fibrillation (AF) plays a prominent role. AF limits the degree of biventricular pacing during CRT, not only when the ventricular rate is fast and highly irregular, but also during periods of of relatively constant rate, by causing fusion and pseudo-fusion complexes. Importantly, achievement of nearly 100% biventricular pacing is necessary to derive benefit from CRT. A simple, albeit irreversible, method to maximize biventricular pacing in patients with AF who are otherwise eligible for CRT is atrioventricular junction (AVJ) ablation. In this review, we discuss the role of AVJ ablation in CRT optimization in patients with AF. The available evidence from observational non-randomized studies suggests that AVJ ablation in patients with AF qualifying for CRT may offer improvement in heart failure symptoms, better survival, and better cardiac function. In light of the inherent limitations of non-randomized studies, further randomized studies are needed to support this treatment option.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. Recommended strategy for atrioventricular junction (AVJ) ablation in patients with atrial fibrillation (AF) for optimization of cardiac resynchronization therapy (CRT) based on available evidence.
See this image and copyright information in PMC

References

    1. Roger Véronique L, Go Alan S, Lloyd-Jones Donald M, Benjamin Emelia J, Berry Jarett D, Borden William B, Bravata Dawn M, Dai Shifan, Ford Earl S, Fox Caroline S, Fullerton Heather J, Gillespie Cathleen, Hailpern Susan M, Heit John A, Howard Virginia J, Kissela Brett M, Kittner Steven J, Lackland Daniel T, Lichtman Judith H, Lisabeth Lynda D, Makuc Diane M, Marcus Gregory M, Marelli Ariane, Matchar David B, Moy Claudia S, Mozaffarian Dariush, Mussolino Michael E, Nichol Graham, Paynter Nina P, Soliman Elsayed Z, Sorlie Paul D, Sotoodehnia Nona, Turan Tanya N, Virani Salim S, Wong Nathan D, Woo Daniel, Turner Melanie B. Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation. 2012 Jan 03;125 (1):e2–e220. - PMC - PubMed
    1. Cleland John, Tageldien Ahmed, Khaleva Olga, Hobson Neil, Clark Andrew L. Should patients who have persistent severe symptoms receive a left ventricular assist device or cardiac resynchronization therapy as the next step? Heart Fail Clin. 2007 Jul;3 (3):267–73. - PubMed
    1. Tracy Cynthia M, Epstein Andrew E, Darbar Dawood, DiMarco John P, Dunbar Sandra B, Estes N A Mark, Ferguson T Bruce, Hammill Stephen C, Karasik Pamela E, Link Mark S, Marine Joseph E, Schoenfeld Mark H, Shanker Amit J, Silka Michael J, Stevenson Lynne Warner, Stevenson William G, Varosy Paul D, Ellenbogen Kenneth A, Freedman Roger A, Gettes Leonard S, Gillinov A Marc, Gregoratos Gabriel, Hayes David L, Page Richard L, Stevenson Lynne Warner, Sweeney Michael O. 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. [corrected]. Circulation. 2012 Oct 02;126 (14):1784–800. - PubMed
    1. McAlister Finlay A, Ezekowitz Justin, Hooton Nicola, Vandermeer Ben, Spooner Carol, Dryden Donna M, Page Richard L, Hlatky Mark A, Rowe Brian H. Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review. JAMA. 2007 Jun 13;297 (22):2502–14. - PubMed
    1. Tang Anthony S L, Wells George A, Talajic Mario, Arnold Malcolm O, Sheldon Robert, Connolly Stuart, Hohnloser Stefan H, Nichol Graham, Birnie David H, Sapp John L, Yee Raymond, Healey Jeffrey S, Rouleau Jean L. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N. Engl. J. Med. 2010 Dec 16;363 (25):2385–95. - PubMed

LinkOut - more resources